Single-nucleotide polymorphisms in ABC drug transporters alter expression and circulating tenofovir in healthy South African women exposed to pre-exposure prophylaxis
Aim: We investigated if single-nucleotide polymorphisms (SNPs) in ATP-binding cassette (ABC) drug transporters alter gene expression and tenofovir disposition in South African women taking Truvada® for HIV prevention. Materials & methods: In 393 women, real-time PCR was used to determine the associations between six SNPs in ABC transporter genes, mRNA expression and circulating-tenofovir. Results: Univariable and multivariable analyses showed that CT and TT relative to CC genotypes for the ABCC4(3463C/T) SNP had significantly higher tenofovir levels. In contrast, the AA genotype for the ABCC4(4976A/G) SNP showed significantly less tenofovir, while mRNA expression was increased. Conclusion: SNPs in the ABCC4 gene may differentially affect gene expression and circulating tenofovir. Their impact may inform on low pre-exposure prophylaxis efficacy and discern effective drugs in clinical trials of African women enriched for certain genotypes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Pharmacogenomics - 24(2023), 11 vom: 01. Juli, Seite 599-613 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zondo, Nomusa M [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 15.09.2023 Date Revised 11.10.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2217/pgs-2023-0058 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360036066 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360036066 | ||
003 | DE-627 | ||
005 | 20231226082145.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2217/pgs-2023-0058 |2 doi | |
028 | 5 | 2 | |a pubmed24n1200.xml |
035 | |a (DE-627)NLM360036066 | ||
035 | |a (NLM)37503696 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zondo, Nomusa M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Single-nucleotide polymorphisms in ABC drug transporters alter expression and circulating tenofovir in healthy South African women exposed to pre-exposure prophylaxis |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.09.2023 | ||
500 | |a Date Revised 11.10.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Aim: We investigated if single-nucleotide polymorphisms (SNPs) in ATP-binding cassette (ABC) drug transporters alter gene expression and tenofovir disposition in South African women taking Truvada® for HIV prevention. Materials & methods: In 393 women, real-time PCR was used to determine the associations between six SNPs in ABC transporter genes, mRNA expression and circulating-tenofovir. Results: Univariable and multivariable analyses showed that CT and TT relative to CC genotypes for the ABCC4(3463C/T) SNP had significantly higher tenofovir levels. In contrast, the AA genotype for the ABCC4(4976A/G) SNP showed significantly less tenofovir, while mRNA expression was increased. Conclusion: SNPs in the ABCC4 gene may differentially affect gene expression and circulating tenofovir. Their impact may inform on low pre-exposure prophylaxis efficacy and discern effective drugs in clinical trials of African women enriched for certain genotypes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a ATP-binding cassette drug transporters | |
650 | 4 | |a African women | |
650 | 4 | |a HIV | |
650 | 4 | |a South Africa | |
650 | 4 | |a Truvada® | |
650 | 4 | |a pre-exposure prophylaxis | |
650 | 4 | |a single-nucleotide polymorphisms | |
650 | 4 | |a tenofovir | |
650 | 7 | |a Tenofovir |2 NLM | |
650 | 7 | |a 99YXE507IL |2 NLM | |
650 | 7 | |a ATP-Binding Cassette Transporters |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a Anti-HIV Agents |2 NLM | |
700 | 1 | |a Sobia, Parveen |e verfasserin |4 aut | |
700 | 1 | |a Sivro, Aida |e verfasserin |4 aut | |
700 | 1 | |a Ngcapu, Sinaye |e verfasserin |4 aut | |
700 | 1 | |a Mansoor, Leila E |e verfasserin |4 aut | |
700 | 1 | |a Mahomed, Sharana |e verfasserin |4 aut | |
700 | 1 | |a Lewis, Lara |e verfasserin |4 aut | |
700 | 1 | |a Ramsuran, Veron |e verfasserin |4 aut | |
700 | 1 | |a Archary, Derseree |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 24(2023), 11 vom: 01. Juli, Seite 599-613 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g number:11 |g day:01 |g month:07 |g pages:599-613 |
856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2023-0058 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |e 11 |b 01 |c 07 |h 599-613 |